Market cap
$732m
Earnings yield vs 10-yr compares what the business earns per pound invested against the 4.73% a 10-year US Treasury note pays for no equity risk. Negative means you are paying up front for growth not yet delivered.
Open-market purchases and sales only. Grants, option exercises, gifts and shares withheld for tax are excluded: they are how people are paid, not what they think.
Net Income (Loss) Per Share Basic net income (loss) per share is calculated by dividing the net income (loss) attributable to common stockholders by the weighted-average number of shares of common stock outstanding for the period. As a result, a cumulative adjustment of $ 7.1 million of revenue was recognized in the first quarter of 2026, which lowered the net loss per share by $ 0.04 for the six months ended June 30, 2026 . As of June 30, 2026, there was no deferred revenue relating to the Astellas Agreement. Deferred revenue was $ 8.6 million as of December 31, 2025. …CytomX Therapeutics, Inc., 10-Q, period ended 2026-06-30, filed 2026-08-06